Biofrontera (BFRI) Gross Profit (2020 - 2025)

Biofrontera's Gross Profit history runs 6 years deep, the most recent figure standing at $14.1 million for Q4 2025.

• In Q4 2025, Gross Profit rose 93.35% year-over-year to $14.1 million; the TTM figure through Dec 2025 stood at $30.7 million (up 64.26% YoY), while the FY2025 annual figure was $30.7 million, up 64.27% from the prior year.
• Gross Profit was $14.1 million for Q4 2025 at Biofrontera, up from $4.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $14.1 million in Q4 2025 to a low of -$7.3 million in Q4 2022.
• Historically, Gross Profit has averaged $5.4 million across 5 years, with a median of $4.5 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Gross Profit sank 181.57% in 2022, then jumped 263.03% in 2023.
• A 5-year view of Gross Profit shows it stood at $9.0 million in 2021, then tumbled by 181.57% to -$7.3 million in 2022, then surged by 263.03% to $12.0 million in 2023, then tumbled by 39.02% to $7.3 million in 2024, then soared by 93.35% to $14.1 million in 2025.
• The last three Gross Profit figures came in at $14.1 million (Q4 2025), $4.9 million (Q3 2025), and $6.4 million (Q2 2025), per Business Quant data.